Study of Toddlers With Language Delay
Status: | Completed |
---|---|
Conditions: | Neurology, Psychiatric, Autism |
Therapuetic Areas: | Neurology, Psychiatry / Psychology |
Healthy: | No |
Age Range: | Any |
Updated: | 3/24/2019 |
Start Date: | April 18, 2011 |
End Date: | June 30, 2017 |
Markers of Autism Spectrum Disorders in At-Risk Toddlers: A Pilot Study
The purpose of this study is to learn more about risk factors for autism by studying the
behavior and brain functioning of toddlers with early communication delays and typically
developing toddlers. Children 12 or 18 months of age with language delays (i.e., no words at
18 months, limited vocalizations at 12 months) and typically developing toddlers may be
eligible to participate. This study will be conducted at the NIH Clinical Center in Bethesda,
Maryland. There will be an initial screening evaluation that will include behavioral
assessment. Eligible participants will then complete a baseline visit that includes an
overnight sleep study that includes Electroencephalogram (EEG) test to measure brain
electrical activity, and an MRI scan. Follow-up visits that include behavioral assessment
will occur every 6-12 months, depending on age at study entry. The final study visit will
occur at 36 months of age and will include behavioral assessment, sleep/EEG study, and MRI.
There is no cost for participation. Compensation will be provided. To find out if your child
qualifies or for more information, please call 301-451-7822 (TTY: 1-866-411-1010) or e-mail
NIMH-ASD@mail.nih.gov. National Institute of Mental Health, National Institutes of Health,
Department of Health & Human Services.
behavior and brain functioning of toddlers with early communication delays and typically
developing toddlers. Children 12 or 18 months of age with language delays (i.e., no words at
18 months, limited vocalizations at 12 months) and typically developing toddlers may be
eligible to participate. This study will be conducted at the NIH Clinical Center in Bethesda,
Maryland. There will be an initial screening evaluation that will include behavioral
assessment. Eligible participants will then complete a baseline visit that includes an
overnight sleep study that includes Electroencephalogram (EEG) test to measure brain
electrical activity, and an MRI scan. Follow-up visits that include behavioral assessment
will occur every 6-12 months, depending on age at study entry. The final study visit will
occur at 36 months of age and will include behavioral assessment, sleep/EEG study, and MRI.
There is no cost for participation. Compensation will be provided. To find out if your child
qualifies or for more information, please call 301-451-7822 (TTY: 1-866-411-1010) or e-mail
NIMH-ASD@mail.nih.gov. National Institute of Mental Health, National Institutes of Health,
Department of Health & Human Services.
Objective
This investigation will focus on two areas: 1) early communication impairments as predictors
of autism spectrum disorder (ASD) and later developmental delays, and 2) the relationship
between communication and evidence of CNS function (sleep, EEG) and structure (MRI DTI and
volumetrics) in young children at risk for ASD. The objective is to delineate early
communicative impairments that predict ASD vs. other developmental delays and to examine how
these impairments correlate with brain abnormalities in both structure and function.
Study Population
We will recruit 64 children [n=32 at 12 months of age (plus or minus 2 months); n=32 at 18
months of age (plus or minus 2 months)] who are at-risk for ASD due to communication/language
delays (at-risk group). The at-risk children will be matched at initial on chronological age,
SES, and sex, to typically developing children (n=75) with no history of developmental
delays. These 139 participants will hereafter be referred to as the toddler sample. At the 36
month final visit, diagnostic status (e.g. ASD, non-ASD specific delays, catch up) will be
determined for children in the at-risk group. In addition, 10 healthy adults, aged 18-40 will
serve as control participants for the purpose of piloting the functional paradigms for the
MRI portion of the protocol.
Design
We propose to conduct a prospective, longitudinal study of toddlers at-risk for ASD compared
to typically developing toddlers. Children will complete behavioral testing and an overnight
Sleep/EEG as well as MRI at either a 12 or 18 month initial. Follow-up visits that include
behavioral assessment will occur at 24 and 36 months for all children (and at 18 months of
age for the 12-month cohort). The Sleep/EEG and MRI will be repeated at the 36 month final
follow-up.
Outcome Measures
Autism symptoms, language status, and cognitive development at 36 months will serve as the
primary outcome measures.
This investigation will focus on two areas: 1) early communication impairments as predictors
of autism spectrum disorder (ASD) and later developmental delays, and 2) the relationship
between communication and evidence of CNS function (sleep, EEG) and structure (MRI DTI and
volumetrics) in young children at risk for ASD. The objective is to delineate early
communicative impairments that predict ASD vs. other developmental delays and to examine how
these impairments correlate with brain abnormalities in both structure and function.
Study Population
We will recruit 64 children [n=32 at 12 months of age (plus or minus 2 months); n=32 at 18
months of age (plus or minus 2 months)] who are at-risk for ASD due to communication/language
delays (at-risk group). The at-risk children will be matched at initial on chronological age,
SES, and sex, to typically developing children (n=75) with no history of developmental
delays. These 139 participants will hereafter be referred to as the toddler sample. At the 36
month final visit, diagnostic status (e.g. ASD, non-ASD specific delays, catch up) will be
determined for children in the at-risk group. In addition, 10 healthy adults, aged 18-40 will
serve as control participants for the purpose of piloting the functional paradigms for the
MRI portion of the protocol.
Design
We propose to conduct a prospective, longitudinal study of toddlers at-risk for ASD compared
to typically developing toddlers. Children will complete behavioral testing and an overnight
Sleep/EEG as well as MRI at either a 12 or 18 month initial. Follow-up visits that include
behavioral assessment will occur at 24 and 36 months for all children (and at 18 months of
age for the 12-month cohort). The Sleep/EEG and MRI will be repeated at the 36 month final
follow-up.
Outcome Measures
Autism symptoms, language status, and cognitive development at 36 months will serve as the
primary outcome measures.
- INCLUSION CRITERIA:
At-risk Group:
1. 12 or 18 months of age (plus or minus 3 months)
2. Limited spoken words (for both the 12 and 18 month groups)
3. Expressive and Receptive scores in the Very Low range on the Mullen Scales of Early
Learning (a standardized observational measure),
Typically Developing Group:
1. 12 or 18 months of age (plus or minor 3 months)
2. Development in nonverbal and verbal areas within age expectations (per scores on all 4
domains of the Mullen Scales of Early learning no more than 1.5 standard deviation
below the mean).
Healthy Adult Group:
1. 18-40 years old
EXCLUSION CRITERIA:
At-risk Group:
1. Primary language spoken in the home is other than English
2. Prematurity at birth (defined as less than 36 weeks gestation), or birth weight
significantly below normal for gestational age (SGA- small for gestational age) or
other significant birth trauma.
3. Motor or other medical impairment deemed responsible for delays (e.g. cerebral palsy;
known genetic disorder)
Typically Developing Group:
1. Primary language spoken in the home is other than English
2. Prematurity at birth (defined as less than 36 weeks gestation); or birth weight
significantly below normal for gestational age (SGA- small for gestational age).
3. Motor or other medical impairment that would interfere with study participation
4. Known genetic disorder
5. Status as a younger sibling of a child diagnosed with autism
Healthy Adult Group:
1. Historical or current psychiatric, neurological, or serious medical illness
2. Primary language is other than English
3. Difficulty hearing (as some sounds and words will be presented during the MRI scan)
4. Head injury with loss of consciousness in the last year
5. Metal in the body which would make having an MRI scan unsafe, such as pacemakers,
medication pumps, aneurysm clips, metallic prostheses (including metal pins and rods,
heart valves or cochlear implants), shrapnel fragments, permanent eye liner or small
metal fragments in the eye that welders and other metal workers may have.
6. Discomfort in small closed spaces (have claustrophobia) so that there would be
discomfort in the MRI machine.
7. Inability to lie comfortably flat on the back for up to 60 minutes in the MRI scanner
8. If female, and pregnant
9. Inability to provide own consent
We found this trial at
1
site
9000 Rockville Pike
Bethesda, Maryland 20892
Bethesda, Maryland 20892
Phone: 800-411-1222
Click here to add this to my saved trials